Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
Conditions: Ischemic Stroke Interventions: Drug: Atorvastatin 40 Mg Oral Tablet; Drug: Rosuvastatin 20mg Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Minor Stroke or TIA
Conditions: Ischemic Stroke Interventions: Drug: Atorvastatin 40mg; Drug: Rosuvastatin 20mg Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
Conditions: Intracranial Atherosclerosis; Cognitive Impairment; Cerebrovascular Event Interventions: Drug: Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin; Procedure: Endovascular therapy,Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin Sponsors: Anhui Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
TADCLOT- a Double Blind Randomized Controlled Trial
Conditions: Stent Thrombosis; Myocardial Infarction, Acute Interventions: Drug: Ticagrelor 90 MG; Drug: Clopidogrel Sponsors: National Institute of Cardiovascular Diseases, Pakistan; PharmEvo Pvt Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
Conditions: Ischemic Stroke; Intracranial Arteriosclerosis; Secondary Prevention; Antiplatelet Drug Interventions: Drug: clopidogrel for 90 days combined with aspirin for 90 days; Drug: clopidogrel for 30 days combined with aspirin for 90 days Sponsors: Sichuan Provincial People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Clopidogrel Versus Cilostazol in Ischemic Stroke
Conditions: Ischemic Stroke Interventions: Drug: Clopidogrel tablet; Drug: Cilostazol 100 MG Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
Conditions: Ischemic Stroke Interventions: Drug: Clopidogrel tablet; Drug: Cilostazol 100 MG Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair
Conditions: Unruptured Intracranial Aneurysm; Flow Diverter; Stent-assisted Coiling; Thromboembolic Events Interventions: Drug: Tirofiban; Drug: aspirin, clopidogrel Sponsors: Beijing Tiantan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease Interventions: Drug: Ticagrelor 60mg; Drug: Clopidogrel Sponsors: University of Florida; Scott R. MacKenzie Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Antiplatelet Therapy After Successful Percutaneous Coronary Intervention for Chronically Occluded Coronary Artery
Conditions: Chronic Total Occlusion Interventions: Procedure: Percutaneous coronary intervention; Drug: Short dual Aspirin/Clopidogrel therapy; Other: Long dual Aspirin/Clopidogrel therapy; Other: Follow-up visit at 1 month; Other: Follow-up visit at 6 months; Other: Follow-up visit at 12 months Sponsors: Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study
Conditions: Dry Age-related Macular Degeneration Interventions: Drug: Aspirin, Clopidogrel, N-acetylcysteine Sponsors: Navamindradhiraj University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects
Conditions: Healthy Interventions: Drug: Clopidogrel 75 mg; Drug: Tegoprazan 25 mg; Drug: Esomeprazole 20mg Sponsors: HK inno.N Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
Conditions: Ischemic Stroke Interventions: Drug: Ticagrelor 90 MG; Drug: Clopidogrel Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
This Study is Two-center, Prospective, Randomized, Open-label, Controlled, Investigator-sponsored Study That Aims to Investigate the Efficacy of Low-dose Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Minor-to-moderate Ischemic Stroke During Hospitalization
Conditions: Ischemic Stroke Interventions: Drug: Colchicine; Drug: Clopidogrel Sponsors: Mikhail Zykov Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization
Conditions: Ischemic Stroke Interventions: Drug: Colchicine; Drug: Clopidogrel Sponsors: Mikhail Zykov Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
